Consistent with our screen and in contrast to the observations with separate cultures, we found that IFNAR1-disrupted cells in this context exhibited a clear competitive advantage over control cells during SARS-CoV-2 infection but not during mock infection (Fig 2F–G, S4). This evidence concerns the gene IFNAR1 and infection.